0000899243-22-000454.txt : 20220104 0000899243-22-000454.hdr.sgml : 20220104 20220104155759 ACCESSION NUMBER: 0000899243-22-000454 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220101 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elsbree David B CENTRAL INDEX KEY: 0001292650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 22505665 MAIL ADDRESS: STREET 1: C/O ACME PACKET, INC. STREET 2: 100 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-01 0 0001492674 T2 Biosystems, Inc. TTOO 0001292650 Elsbree David B 101 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2022-01-01 4 M 0 32258 A 202981 D Common Stock 10000 I By spouse Restricted Stock Units 2022-01-01 4 M 0 32258 0.00 A Common Stock 32258 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. On January 1, 2021 the reporting person was granted 32,258 restricted stock units that vested on January 1, 2022. /s/ John Sprague, Attorney-in-Fact 2022-01-04